Shear Stress‐Induced Release of Nitric Oxide From Endothelial Cells Grown on Beads
暂无分享,去创建一个
Jon M. Fukuto | L. Ignarro | J. Fukuto | G. Buga | Georgette M. Buga | Michele E. Gold | Louis J. Ignarro | M. E. Gold | M. Gold
[1] F. Murad,et al. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. , 1978, Advances in cyclic nucleotide research.
[2] S. Vatner,et al. Reactive Dilation of Large Coronary Arteries in Conscious Dogs , 1984, Circulation research.
[3] B. Zetter,et al. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein , 1984, The Journal of cell biology.
[4] L. Ignarro,et al. NG-amino-L-arginine: a new potent antagonist of L-arginine-mediated endothelium-dependent relaxation. , 1990, Biochemical and biophysical research communications.
[5] L. Ignarro,et al. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. , 1985, Annual review of pharmacology and toxicology.
[6] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[7] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[8] S. Rodbard. Vascular caliber. , 1975, Cardiology.
[9] M. Peach,et al. Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. , 1982 .
[10] S. S. Hull,et al. Endothelium-dependent flow-induced dilation of canine femoral and saphenous arteries. , 1986, Blood vessels.
[11] S. Leraand,et al. Dilatation of a medium-sized artery immediately after local changes of blood pressure and flow as measured by ultrasonic technique. , 1970, Acta physiologica Scandinavica.
[12] L. Ignarro,et al. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. , 1981, Canadian journal of physiology and pharmacology.
[13] L. Ignarro,et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.
[14] T. Rink,et al. Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? , 1987, Nature.
[15] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[16] F. Murad,et al. Nω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation , 1990 .
[17] D. Edwards,et al. The role of EDRF in flow distribution: a microangiographic study of the rabbit isolated ear. , 1989, Microvascular research.
[18] A. Gibson,et al. l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro , 1990, British journal of pharmacology.
[19] E. Bassenge,et al. Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: indirect, flow-dependent, endothelium-mediated dilation and direct smooth muscle relaxation. , 1983, Zeitschrift fur Kardiologie.
[20] D. Harrison,et al. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide , 1990, Nature.
[21] U. Förstermann,et al. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. , 1984, Journal of cardiovascular pharmacology.
[22] P. Davies,et al. Haemodynamic shear stress activates a K+ current in vascular endothelial cells , 1988, Nature.
[23] S. Doležel,et al. Role of endothelium in the control of arterial diameter by blood flow. , 1985, Blood vessels.
[24] S. Moncada,et al. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. , 1988, Biochemical and biophysical research communications.
[25] L. Ignarro,et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Peach,et al. Role of calcium in endothelium-dependent relaxation of arterial smooth muscle. , 1987, The American journal of cardiology.
[27] N. Voelkel,et al. Altering hydrodynamic variables influences PGI2 production by isolated lungs and endothelial cells. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.
[28] J. Bevan,et al. Flow-dependent dilation in myograph-mounted resistance artery segments. , 1988, Blood vessels.
[29] L. Ignarro,et al. Endothelium‐Derived Relaxing Factor From Pulmonary Artery and Vein Possesses Pharmacologic and Chemical Properties Identical to Those of Nitric Oxide Radical , 1987, Circulation research.
[30] H. Sparks,et al. Mediation of flow-dependent arterial dilation by endothelial cells. , 1986, Circulatory shock.
[31] M. Lie,et al. Local Regulation of Vascular Cross Section during Changes in Femoral Arterial Blood Flow in Dogs , 1970, Circulation research.
[32] L. Ignarro,et al. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. , 1989, Biochemical and biophysical research communications.
[33] M. Peach,et al. Endothelium‐Derived Vascular Relaxing Factor , 1985, Hypertension.
[34] L. Ignarro,et al. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. , 1979, Journal of cyclic nucleotide research.
[35] P. Vanhoutte,et al. Flow-induced release of endothelium-derived relaxing factor. , 1986, The American journal of physiology.
[36] P. Majerus,et al. Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. , 1977, Biochemical and biophysical research communications.
[37] R Busse,et al. Crucial role of endothelium in the vasodilator response to increased flow in vivo. , 1986, Hypertension.
[38] C. Nathan,et al. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells , 1989, The Journal of experimental medicine.
[39] L. Ignarro,et al. EDRF generation and release from perfused bovine pulmonary artery and vein. , 1988, European journal of pharmacology.
[40] F. ten Hoor,et al. Prostacyclin production of the isolated pulsatingly perfused rat aorta. , 1982, Journal of pharmacological methods.
[41] S Prophet,et al. Characteristics of Flow‐Mediated Brachial Artery Vasodilation in Human Subjects , 1989, Circulation research.
[42] L V McIntire,et al. Flow effects on prostacyclin production by cultured human endothelial cells. , 1985, Science.
[43] G. Rubanyi. Endothelium-dependent pressure-induced contraction of isolated canine carotid arteries. , 1988, The American journal of physiology.